Literature DB >> 18381090

The role of the hematologist/oncologist in the care of patients with vascular anomalies.

Denise M Adams1, Mary Sue Wentzel.   

Abstract

Pediatric hematologist/oncologists have a critical role in the diagnosis and management of patients who have complex vascular anomalies. They provide the clinical and medical skills needed to diagnose, treat, and manage these patients. Hematologist/oncologists also provide support for clinical trials and drug development to further treatment options for these patients.

Entities:  

Mesh：

Year:  2008        PMID： 18381090     DOI： 10.1016/j.pcl.2008.01.007

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  7 in total

1.  The role of hematologists in a changing United States health care system.

Authors:  Paul J Wallace; Nathan T Connell; Janis L Abkowitz
Journal:  Blood       Date:  2015-03-06       Impact factor: 22.113

2.  Medical therapy for pediatric vascular anomalies.

Authors:  Judith F Margolin; Heather Mills Soni; Sheena Pimpalwar
Journal:  Semin Plast Surg       Date:  2014-05       Impact factor: 2.314

3.  Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.

Authors:  Denise M Adams; Cameron C Trenor; Adrienne M Hammill; Alexander A Vinks; Manish N Patel; Gulraiz Chaudry; Mary Sue Wentzel; Paula S Mobberley-Schuman; Lisa M Campbell; Christine Brookbank; Anita Gupta; Carol Chute; Jennifer Eile; Jesse McKenna; Arnold C Merrow; Lin Fei; Lindsey Hornung; Michael Seid; A Roshni Dasgupta; Belinda H Dickie; Ravindhra G Elluru; Anne W Lucky; Brian Weiss; Richard G Azizkhan
Journal:  Pediatrics       Date:  2016-01-18       Impact factor: 7.124

4.  A pediatric posterior neck venous malformation with an endocranial extension.

Authors:  Moncef Sellami; Mariam Ben Ayed; Saadia Makni; Tahya Sellami Boudawara; Souha Kallel; Ilhem Charfeddine
Journal:  SAGE Open Med Case Rep       Date:  2022-07-18

5.  Sirolimus for the treatment of children with various complicated vascular anomalies.

Authors:  Herwig Lackner; Anna Karastaneva; Wolfgang Schwinger; Martin Benesch; Petra Sovinz; Markus Seidel; Daniela Sperl; Sofia Lanz; Emir Haxhija; Friedrich Reiterer; Erich Sorantin; Christian E Urban
Journal:  Eur J Pediatr       Date:  2015-06-04       Impact factor: 3.183

6.  Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinib.

Authors:  Changhoon Yoo; Jeong-Eun Kim; Shin-Kyo Yoon; Song Cheol Kim; Jin-Hee Ahn; Tae Won Kim; Cheolwon Suh; Jae-Lyun Lee
Journal:  Sarcoma       Date:  2009-05-20

7.  Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.

Authors:  C Emoto; T Fukuda; T N Johnson; D M Adams; A A Vinks
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.